Score DIC (ISTH) and sepsis-induced coagulopathy, treat the cause, and give products only for bleeding or procedures.
At the bedside
- 1
Score
ISTH overt DIC score ≥ 5 (platelets, D-dimer, PT, fibrinogen); in sepsis, SIC score ≥ 4 identifies earlier coagulopathy. Repeat daily: trends matter.
- 2
Treat the cause
Source control and antibiotics in sepsis; delivery in obstetric DIC; ATRA for APML; antivenom for snakebite coagulopathy.
- 3
Bleeding or procedure
Platelets if < 50 × 10⁹/L and bleeding; FFP 15-30 mL/kg if PT/aPTT > 1.5× with bleeding; fibrinogen < 150 mg/dL with bleeding: cryoprecipitate.
- 4
No bleeding
Platelets only if < 10-20 × 10⁹/L; do not give FFP for lab values alone.
- 5
Thrombosis-predominant
Therapeutic heparin in DIC with thrombosis (e.g. purpura fulminans, solid tumour) if not bleeding; VTE prophylaxis in all non-bleeding DIC.
- 6
Antifibrinolytics
Generally avoid TXA in sepsis-DIC; consider in hyperfibrinolytic DIC (APML, trauma, some obstetric).
ISTH overt DIC score (with an underlying cause)
| Parameter | Points |
|---|---|
| Platelets > 100 × 10⁹/L | 0 |
| Platelets 50-100 | 1 |
| Platelets < 50 | 2 |
| D-dimer/FDP no increase | 0 |
| Moderate increase | 2 |
| Strong increase | 3 |
| PT prolonged < 3 s | 0 |
| PT prolonged 3-6 s | 1 |
| PT prolonged > 6 s | 2 |
| Fibrinogen > 100 mg/dL | 0 |
| Fibrinogen ≤ 100 mg/dL | 1 |
Score ≥ 5 = overt DIC (repeat daily); < 5 suggests non-overt DIC (repeat in 1-2 days). D-dimer cut-offs depend on local assay.
Sepsis-induced coagulopathy (SIC) score
| Parameter | 1 point | 2 points |
|---|---|---|
| PT-INR | > 1.2 | > 1.4 |
| Platelets (× 10⁹/L) | 100-149 | < 100 |
| SOFA (respiratory, cardiovascular, hepatic, renal sum) | 1 | ≥ 2 |
SIC ≥ 4 (with platelet + INR total > 2).
References
- 1
- 2
- 3
Suspected DIC
Step 1 of ~5
ISTH DIC score (SIC in sepsis); treat underlying cause
Based on Wada H, Thachil J, Di Nisio M, et al. Educational use; follow local protocol.
Pathophysiology
Tissue factor expression on monocytes and endothelium drives thrombin generation, while anticoagulant pathways (antithrombin, protein C) and fibrinolysis (raised PAI-1 in sepsis) are suppressed, producing microthrombi and organ failure; consumption leads to bleeding.
Evidence
- ISTH DIC score (2001) and harmonised guidance (2013) [Taylor 2001; Wada 2013].
- SIC criteria identify patients with sepsis coagulopathy earlier than overt DIC [Iba 2017].
Controversies
- Anticoagulant therapy (antithrombin, thrombomodulin, heparin) in sepsis-induced coagulopathy: used in Japan, not recommended routinely elsewhere.
🇮🇳 India notes
- Snakebite (Russell's viper, saw-scaled viper) causes venom-induced consumption coagulopathy that responds to antivenom, not FFP; use the 20-minute whole blood clotting test (20WBCT).
- Falciparum malaria, dengue and leptospirosis are common Indian causes of DIC-like coagulopathy.
References
- 1
- 2
- 3
Test yourself
Module quiz · score 70% to complete the module
Educational reference for trained clinicians. Check doses against your hospital protocol and the patient in front of you.

